Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide-Reference-Cited by-同舟云学术

Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide

Published:2005-06 Issue:6 Volume:16 Page:942-949
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Brada M.,Ashley S.,Dowe A.,Gonsalves A.,Huchet A.,Pesce G.,Reni M.,Saran F.,Wharram B.,Wilkins M.,Wilkins P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/6/942/482882/mdi183.pdf

Reference35 articles.

1. Chemotherapy;Rampling,1997

2. Single-agent chemotherapy of brain tumors. A five-year review;Wilson;Arch Neurol,1976

3. Dear KB, Loeffler JS et al. Meta analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults;Fine;Cancer,1993

4. Chemotherapy in adult high-grade glioma: a systematic review and meta- analysis of individual patient data from 12 randomised trials;Stewart;Lancet,2002

5. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial;Thomas;J Clin Oncol,2001

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the impact of adjuvant treatment on the prognosis of patients with inoperable glioblastoma undergoing biopsy only: does the survival benefit outweigh the treatment effort?;Neurosurgical Review;2022-02-23

2. Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study;Journal of Neuro-Oncology;2019-06-07

3. Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients;Clinical and Translational Oncology;2018-05-08

4. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial;Acta Oncologica;2017-07-04

5. A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma;International Journal of Radiation Oncology*Biology*Physics;2017-03